Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine effect on remifentanil requirement during propofol anesthesia
ChiCTR-TRC-13003216Phase 4Completed
- Sponsor
- Zhenjiang First People's Hospital
- Start
- Jun 2013
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine, remifentanil and propofol in breast neoplasia (3 arms), sponsored by Zhenjiang First People's Hospital. Primary endpoint: Effect-site concentration of remifentanil before skin incision. Started Jun 2013; status: completed.
02
Drugs
dexmedetomidineremifentanilpropofol
03
Conditions
breast neoplasia
Beyond the preview
Go deeper on ChiCTR-TRC-13003216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003216.